Correlation Between Neuropace and Pulmonx Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Pulmonx Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Pulmonx Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Pulmonx Corp, you can compare the effects of market volatilities on Neuropace and Pulmonx Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Pulmonx Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Pulmonx Corp.

Diversification Opportunities for Neuropace and Pulmonx Corp

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Neuropace and Pulmonx is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Pulmonx Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmonx Corp and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Pulmonx Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmonx Corp has no effect on the direction of Neuropace i.e., Neuropace and Pulmonx Corp go up and down completely randomly.

Pair Corralation between Neuropace and Pulmonx Corp

Given the investment horizon of 90 days Neuropace is expected to generate 1.45 times more return on investment than Pulmonx Corp. However, Neuropace is 1.45 times more volatile than Pulmonx Corp. It trades about 0.28 of its potential returns per unit of risk. Pulmonx Corp is currently generating about 0.06 per unit of risk. If you would invest  590.00  in Neuropace on August 24, 2024 and sell it today you would earn a total of  310.00  from holding Neuropace or generate 52.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  Pulmonx Corp

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Pulmonx Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pulmonx Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Neuropace and Pulmonx Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Pulmonx Corp

The main advantage of trading using opposite Neuropace and Pulmonx Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Pulmonx Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmonx Corp will offset losses from the drop in Pulmonx Corp's long position.
The idea behind Neuropace and Pulmonx Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets